Impact of PKCδ on estrogen receptor localization and activity in breast cancer cells

Oncogene

Volumn 24, Issue 31, 2005, Pages 4946-4955

  De Servi, Barbara ^a   Hermani, Alexander ^a   Medunjanin, Senad ^a   Mayer, Doris ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast cancer; Estrogen receptor; GSK3; Phorbol ester; PKC

Indexed keywords

BRYOSTATIN 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GLYCOGEN SYNTHASE KINASE 3; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C DELTA; ROTTLERIN; ESTROGEN RECEPTOR; PRKCD PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL NUCLEUS; FEMALE; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REPORTER GENE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 23744476859     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208676     Document Type: Article

References (47)

1. Beato M, Herrlich P and Schütz G. (1995). Cell, 83, 851-857.
2. Borner C, Wyss R, Regazzi R, Eppenberger U and Fabbro D. (1987). Int. J. Cancer, 40, 344-348.
3. Bunone G, Briand P-A, Miksicek RJ and Picard D. (1996). EMBO J., 15, 2174-2183.
4. Cho H and Katzenellenbogen BS. (1993). Mol. Endocrinol., 7, 441-452.
5. Dauvois S, White R and Parker MG. (1993). J. Cell Sci., 106, 1377-1388.
6. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA and Messing RO. (2000). Am. J. Lung Cell. Mol. Physiol., 279, L429-L438.
7. Fawell SE, Lees JA, White R and Parker MG. (1990). Cell, 60, 953-962.
8. Frame S and Cohen P. (2001). Biochem. J., 359, 1-16.
9. Grimes CA and Jope RS. (2001). Prog. Neurobiol., 65, 391-426.
10. Gschwendt M. (1999). Eur. J. Biochem., 259, 555-564.
11. Gschwendt M, Müller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G and Marks F. (1994). Biochem. Biophys. Res. Commun., 199, 93-98.
12. Hall JM, Couse JF and Korach KS. (2001). J. Biol. Chem., 276, 36869-36872.
13. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA and Korach KS. (1992). Proc Natl Acad Sci USA, 89, 4658-4662.
14. Joel PB, Traish AM and Lannigan DA. (1995). Mol. Endocrinol., 9, 1041-1052.
15. Jope RS and Johnson GV. (2004). Trends Biochem. Sci., 29, 95-102.
16. Keshamouni VG, Mattingly RR and Reddy KB. (2002). J. Biol. Chem., 277, 22558-22565.
17. Kikkawa U, Matsuzaki H and Yamamoto T. (2002). J. Biochem. (Tokyo), 132, 831-839.
18. Kiley SC, Clark KJ, Duddy SK, Welch DR and Jaken S. (1999a). Oncogene, 18, 6748-6757.
19. Kiley SC, Clark KJ, Goodnough M, Welch DR and Jaken S. (1999b). Cancer Res., 59, 3230-3238.
20. Kraft AS, Anderson WB, Cooper HL and Sando JJ. (1982). J. Biol. Chem., 257, 13193-13196.
21. Kumar V and Chambon P. (1988). Cell, 55, 145-156.
22. Laemmli U. (1970). Nature, 227, 680-685.
23. Lahooti H, Thorsen T and Aakvaag A. (1998). J. Mol. Endocrinol., 20, 245-259.
24. Lannigan DA. (2003). Steroids, 68, 1-9.
25. Le Bail JC, Marre-Fournier F, Nicolas JC and Habrioux G. (1998). Steroids, 63, 678-683.
26. Le Goff P, Montano MM, Schodin DJ and Katzenellenbogen BS. (1994). J. Biol. Chem., 269, 4458-4466.
27. Liu WS and Heckman CA. (1998). Cell. Signal., 10, 529-542.
28. Longo M, Brama M, Marino M, Bernardini S, Korach KS, Wetsel WC, Scandurra R, Faraggiana T, Spera G, Baron R, Teti A and Migliaccio S. (2004). Bone, 34, 100-111.
29. Lorenzo PS, Bogi K, Hughes KM, Beheshti M, Bhattacharyya D, Garfield SH, Pettit GR and Blumberg PM. (1999). Cancer Res., 59, 6137-6144.
30. Maizels ET, Shanmugam M, Lamm ML and Hunzicker-Dunn M. (1996). Mol. Cell. Endocrinol., 122, 213-221.
31. Marino M, Distefano E, Caporali S, Ceracchi G, Pallottini V and Trentalance A. (2001). J. Cell Physiol., 188, 170-177.
32. Martin MB, Garcia-Morales P, Stoica A, Solomon HB, Pierce M, Katz D, Zhang S, Danielsen M and Saceda M. (1995). J. Biol. Chem., 270, 25244-25251.
33. Matthews J and Gustafsson JA. (2003). Mol. Interv., 3, 281-292.
34. McCracken MA, Miraglia LJ, McKay RA and Strobl JS. (2003). Mol. Cancer Ther., 2, 273-281.
35. Migliaccio A, Rotondi A and Auricchio F. (1986). EMBO J., 5, 2867-2872.
36. Migliaccio A, Pagano M and Auricchio F. (1993). Oncogene, 8, 2183-2191.
37. Mochly-Rosen D and Gordon AS. (1998). FASEB J., 12, 35-42.
38. Parker MG, Arbuckle N, Dauvois S, Danielian P and White R. (1993). Ann. NY Acad. Sci., 684, 119-126.
39. Ree AH, Landmark BF, Walaas SI, Lahooti H, Eikvar L, Eskild W and Hansson V. (1991). Endocrinology, 129, 339-344.
40. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J and Gannon F. (2003). Mol. Cell, 11, 695-707.
41. Saceda M, Knabbe C, Dickson RB, Lippman ME, Bronzert D, Lindsey RK, Gottardis MM and Martin MB. (1991). J. Biol. Chem., 266, 17809-17814.
42. Shanmugam M, Krett NL, Maizels ET, Cutler Jr RE, Peters CA, Smith LM, O'Brien ML, Park-Sarge OK, Rosen ST and Hunzicker-Dunn M. (1999). Mol. Cell. Endocrinol., 148, 109-118.
43. Toker A. (1998). Front. Biosci., 3, d1134-d1147.
44. Tonetti DA, Chisamore MJ, Grdina W, Schurz H and Jordan VC. (2000). Br. J. Cancer, 83, 782-791.
45. Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, Iqbal K and Takeda M. (2000). FEBS Lett., 469, 111-117.
46. Tzukerman M, Zhang XK and Pfahl M. (1991). Mol. Endocrinol., 5, 1983-1992.
47. Valette A, Gas N, Jozan S, Roubinet F, Dupont MA and Bayard F. (1987). Cancer Res., 47, 1615-1620.